COVID-19 UPDATE: Regenexx is committed to the health and safety of our patients. You may now be seen in clinic or via telemedicine for virtual/online or phone visits.
LEARN MORE
Our physicians are available via telemedicine to continue to give you the care you need during this difficult time. Learn more.

Orthopedic Stem Cell Research

Regenexx Is Committed to Innovation.

Regenexx is built upon our commitment to research and innovation. We were the first to use stem cells to treat orthopedic injuries, and we’ve published 44%* of all research world-wide in the area.

Regenexx® stem cell procedures have been studied extensively for more than a decade and our patients are part of the world’s largest human mesenchymal stem cell re-implantation database for orthopedic purposes. We are the only orthopedic stem cell providers with this volume of data to draw upon and to regularly summarize outcome data from our patient registry and make it available to the public.

Our Recently Published Stem Cell Safety Paper is the Largest in the World

In 2016, Regenexx published the world’s largest (2,372 patients) stem cell safety paper in any medical indication (not just orthopedics). This is the most in-depth analysis of safety available. In addition, it’s the longest follow-up period for a large group of patients where all complaints are reported. Finally, the data was collected at multiple treatment sites, and all complications that were considered significant were reviewed by a panel of five physicians and scientists who were not in any way affiliated with Regenexx (independent adjudication of SAEs).

We continue to explore new approaches and techniques in our dedicated research and development laboratory. Everything we do throughout our network of physicians is based on this research. We know what works, and we’ve refined our treatment protocols over more than a decade. No one else using regenerative medicine to treat orthopedic injuries can make a similar claim.

We make results from our outcomes database publicly available. Regenexx is the only orthopedic stem-cell network with this volume of data, and we are the only ones to regularly publish patient outcome data with complete transparency. We want to make what we’ve learned available to you so that you can make an informed decision about your best treatment option.

Beyond treating patients, Regenexx also develops new, ground-breaking medical technologies in the field of Interventional Orthopedics. We’ve filed a number of patents on our devices and biologic treatments. Our patents on theses underlying technologies set us apart. No one else is doing what we do.

*CUMULATIVE N OF PATIENTS PUBLISHED & TREATED WITH BONE MARROW STEM CELLS AS OF JULY 2018

Read More About this Topic

Is Regenexx Right For You?

Request a free Regenexx Info Packet

REGENEXX WEBINARS

Learn about the #1 Stem Cell & Platelet Procedures for treating arthritis, common joint injuries & spine pain.

Join a Webinar

RECEIVE BLOG ARTICLES BY EMAIL

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Subscribe to the Blog

CONTACT US

9035 Wadsworth Pkwy #1000
Westminster, CO 80021
888-525-3005

FOLLOW US

Copyright © Regenexx 2020. All rights reserved. | Privacy Policy

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.

LinkedIn
Email